Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWCH
2226
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $3.32M | ﹤0.01% |
223,912
+17,796
| +9% | +$270K |
|
2227
Bally's
BALY
$660M
| $3.32M | ﹤0.01% |
129,323
-10,231
| -7% | -$247K |
|
2228
Arrow Financial
AROW
$723M
| $3.3M | ﹤0.01% |
98,344
+1,814
| +2% | +$57.1K |
|
|
MDR
2229
DELISTED
McDermott International
MDR
| $3.3M | ﹤0.01% |
4,879,519
+2,422,673
| +99% | +$3.1M |
|
|
CLVS
2230
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.3M | ﹤0.01% |
316,534
+6,083
| +2% | +$44.2K |
|
2231
Carter Bankshares
CARE
$757M
| $3.29M | ﹤0.01% |
138,526
+3,437
| +3% | +$71.1K |
|
|
KRTX
2232
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.28M | ﹤0.01% |
43,584
+11,329
| +35% | +$496K |
|
2233
Levi Strauss
LEVI
$8.63B
| $3.28M | ﹤0.01% |
169,829
+3,005
| +2% | +$53.6K |
|
2234
MacroGenics
MGNX
$259M
| $3.26M | ﹤0.01% |
299,664
+5,625
| +2% | +$55.7K |
|
2235
American Vanguard Corp
AVD
$62.8M
| $3.25M | ﹤0.01% |
166,841
+3,852
| +2% | +$60.6K |
|
|
BDSI
2236
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.25M | ﹤0.01% |
513,311
-6,206
| -1% | -$36.5K |
|
2237
TherapeuticsMD
TXMD
$24.1M
| $3.24M | ﹤0.01% |
26,801
+2,967
| +12% | +$427K |
|
|
STFC
2238
DELISTED
State Auto Financial Corp
STFC
| $3.24M | ﹤0.01% |
104,368
+2,251
| +2% | +$72.5K |
|
|
HONE
2239
DELISTED
HarborOne Bancorp
HONE
| $3.24M | ﹤0.01% |
294,478
+7,772
| +3% | +$81.5K |
|
|
NVEE
2240
DELISTED
NV5 Global
NVEE
| $3.23M | ﹤0.01% |
256,064
+4,472
| +2% | +$65.2K |
|
2241
Peapack-Gladstone Financial
PGC
$822M
| $3.21M | ﹤0.01% |
103,910
-6,529
| -6% | -$192K |
|
|
RC
2242
Ready Capital
RC
$294M
| $3.21M | ﹤0.01% |
208,194
+26,752
| +15% | +$421K |
|
|
JAG
2243
DELISTED
Jagged Peak Energy Inc.
JAG
| $3.21M | ﹤0.01% |
378,146
+6,623
| +2% | +$48.4K |
|
2244
Digital Turbine
APPS
$1.53B
| $3.21M | ﹤0.01% |
449,994
+15,891
| +4% | +$118K |
|
2245
Lindblad Expeditions
LIND
$2.26B
| $3.2M | ﹤0.01% |
195,661
+3,953
| +2% | +$63.2K |
|
|
ROCC
2246
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $3.2M | ﹤0.01% |
105,393
+25,300
| +32% | +$673K |
|
|
CBB
2247
DELISTED
Cincinnati Bell Inc.
CBB
| $3.2M | ﹤0.01% |
305,186
+7,420
| +2% | +$45.5K |
|
2248
BrightView Holdings
BV
$1.08B
| $3.19M | ﹤0.01% |
189,104
+3,524
| +2% | +$61.3K |
|
|
VTLE
2249
DELISTED
Vital Energy
VTLE
| $3.19M | ﹤0.01% |
55,567
+2,587
| +5% | +$125K |
|
|
MDLA
2250
DELISTED
Medallia, Inc.
MDLA
| $3.18M | ﹤0.01% |
102,336
+4,766
| +5% | +$141K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.